• TET2 Metabolite Binding: Biochemistry and STD NMR

  2026-08-18

  Zhang, Cheng, and Ye present an orthogonal workflow that combines biochemical activity assays with saturation transfer difference NMR to validate metabolite binding and regulation of human TET2 dioxygenase. The protocol distinguishes TET2 activators from inhibitors and offers a practical framework for investigating how metabolic changes influence epigenetic enzyme function.

• Sumatriptan Succinate: Mechanism & Research Use

  2026-08-17

  Sumatriptan Succinate is a selective 5-HT1 receptor agonist used for acute migraine treatment and serotonergic signaling research. Its established 5-HT1B/1D pharmacology is complemented by newly characterized MAO A and CYP-mediated metabolism, creating a useful but bounded migraine research compound.

• Mapping Fzd5–Cholesterol Signaling with Biotin Azide

  2026-08-17

  A translational strategy for using Biotin Azide and click-enabled affinity workflows to interrogate how cholesterol regulates Frizzled5 maturation, trafficking, and Wnt/β-catenin signaling in pancreatic cancer.

• Spermine, Ion Channels, and Nuclear Membrane Fusion

  2026-08-16

  Spermine is more than a metabolic polyamine: its voltage-sensitive blockade of inward rectifier potassium channels offers a controllable entry point into membrane excitability and cellular organization. This article connects that established mechanism with emerging CLCC1 biology in herpesvirus nuclear egress while distinguishing evidence from forward-looking translational hypotheses.

• Geneticin for Cell Selection and Assay Design

  2026-08-15

  Geneticin, also called G418 Sulfate, supports reproducible stable-cell selection and can be adapted to carefully controlled Dengue virus inhibition assays. This guide connects selection pressure, metabolic assay design, and troubleshooting so researchers can use G-418 without confusing antibiotic stress with the biology under study.

• Psora 4: Designing Kv1.3 Pharmacology Assays

  2026-08-15

  Psora 4 is a selective Kv1.3 blocker for dissecting T cell excitability, calcium entry, and effector memory responses. This guide translates KCNE4-dependent pharmacology into practical assay design and interprets its relevance to autoimmune kidney inflammation models.

• EZ Cap™ Cas9 mRNA for CRISPR Workflows

  2026-08-14

  EZ Cap™ Cas9 mRNA (5-moUTP) is an in vitro transcribed Cas9 mRNA reagent for transient CRISPR-Cas9 genome editing. Its Cap1 structure, 5-methoxyuridine modification, and poly(A) tail are designed to support translation, stability, and reduced innate immune activation in research workflows.

• AT13387: Hsp90 Inhibitor for Cancer Research

  2026-08-14

  AT13387 is an orally bioavailable Hsp90 inhibitor with nanomolar binding affinity and reported activity in melanoma-cell assays. Its distinct scaffold, client-protein degradation mechanism, and tumor-retention profile support use in cancer biology research, while current evidence does not establish antiviral or NINJ1-directed activity.

• Apicidin: HDAC Inhibition and Research Applications

  2026-08-13

  Apicidin is a potent histone deacetylase inhibitor with reported nanomolar activity against HDAC3 and HDAC6. Evidence supports its use as an anti-proliferative agent, anti-angiogenesis compound, and mechanistic probe, while recent oocyte data establish important reproductive-toxicity boundaries.

• Fluoxetine HCl Workflows for Serotonin Research

  2026-08-13

  Build reproducible receptor, membrane-binding, and behavioral workflows with Fluoxetine HCl, a practical tool for dissecting serotonergic signaling. The guide connects concentration-aware assay design with motivation, neurogenesis, depression research, and developmental SSRI questions while emphasizing solvent control and interpretation limits.

• Griseofulvin: A Mechanism-First Assay Guide

  2026-08-12

  Griseofulvin is a microtubule associated inhibitor whose value extends beyond routine antifungal studies. This mechanism-first guide connects fungal cell mitosis inhibition with multiparametric aneugenicity assay design, product handling, and evidence-based interpretation.

• STING Agonist-1 and the ESCC Immune Circuit

  2026-08-12

  A translational perspective on how STING agonist-1 can help researchers interrogate the STING–TRAF2–IRF4 axis, B cell activation, and tertiary lymphoid structure biology in esophageal squamous cell carcinoma.

• Chronic Stress, Mitochondria, and Depression-Like Behavior

  2026-08-11

  A February 2025 study in rats connects chronic unpredictable mild stress with mitochondrial dysfunction and neuroinflammation in the hippocampus and prefrontal cortex. Its pharmacological rescue experiment with the mitochondrial antioxidant MnTBAP strengthens the hypothesis that impaired mitochondrial function contributes to stress-induced depression-like behavior.

• A40926: From Glycopeptide to Translational Strategy

  2026-08-10

  A mechanistic and strategic guide to using A40926 as a dalbavancin precursor, bacterial cell wall synthesis inhibitor, and platform for Gram-positive, MRSA, Neisseria gonorrhoeae, and biosynthetic pathway research.

• ATP Solution and the Next Wave of p21 mRNA Translation

  2026-08-09

  A translational perspective on how ATP-dependent biochemical control can strengthen p21 mRNA-LNP research, from in vitro transcription and kinase assays to localized bladder cancer therapy development.

458 records 8/31 page Previous Next First page 上5页 678910 下5页 Last page